Patent details
EP4054584 Title: METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN INHIBITOR AND A SODIUM DEPENDENT GLUCOSE TRANSPORT 2 INHIBITOR
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- EP4054584
- WO Application Number:
- IB2020000912
- Type:
- European Patent Granted for NL
- Status:
- Patent in Force
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP20884269.0
- WO Publication Number:
- WO2021090061
- EPO Publication Language:
- English
- SPC Number:
- First Applicant Residence Country:
- Canada (CA)
- Publications:
Dates
- Filing date:
- 04/11/2020
- Grant date:
- 09/07/2025
- EP Publication Date:
- 14/09/2022
- WO Publication Date:
- 14/05/2021
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- 14/08/2025
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 09/07/2025
- EP B1 Publication Date:
- 09/07/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 03/11/2040
- Lapsed By Expiration Date:
- Patent Validated Date:
- 28/08/2025
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 09/07/2025
- Name:
- Resverlogix Corp.
- Address:
- 300, 4820 Richard Road SW, Calgary, AB T3E 6L1, Canada (CA)
Agent
- Name:
- ir. F.A. Geurts c.s.
- From:
- 27/08/2025
- Address:
- Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
- To:
Inventor
1
- Name:
- LEBIODA, Kenneth Eugene
- Address:
- Calgary, AB T3Z 3T2, Canada (CA)
2
- Name:
- HALLIDAY, Christopher Ross Armstrong
- Address:
- Calgary, AB T2G 5P9, Canada (CA)
3
- Name:
- KHAN, Aziz Naeem
- Address:
- Calgary, AB T3E 7M7, Canada (CA)
Priority
- Priority Patent Number:
- 201962930860 P
- Priority Date:
- 05/11/2019
- Priority Country:
- United States of America (US)
Classification
- IPC or IDT classification:
- A61K 31/517; A61P 9/00; C07D 239/91; A61K 31/70; A61K 31/7042; A61K 31/7048; A61K 45/06;
Publication
Bulletin
1
- Bulletin Heading:
- EP3
- Journal edition number:
- 36/25
- Publication date:
- 03/09/2025
- Description:
- European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
2
- Bulletin Heading:
- EP2
- Journal edition number:
- 28/25
- Publication date:
- 09/07/2025
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
- Issue number:
- 202528
- Publication date:
- 09/07/2025
- Description:
- Grant (B1)
Annual Fee
- Annual Fee(s) Due Date:
- 30/11/2026
- Annual Fee Number:
- 7
- Annual Fee Amount:
- 220 Euro
- Last Annual Payment Date:
- 12/09/2025
- Last Annual Fee Paid Number:
- 6
- Last Annual Fee Paid Amount:
- 160 Euro
- Payer:
- Computer Patent Annuities Limited (CPA)
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 27/08/2025 | Outgoing Correspondence | Letter no formal defects | 1 | /1/5/3/3/3/0801133351/docs/ep20884269.0_1_ep4054584671458l271.pdf | ||
| 14/08/2025 | Claims | First filed claims | 3 | /1/5/3/3/3/0801133351/docs/ep20884269.0_0_claims20250814164515985.pdf |